Home
About
Overview
Sharing Data
ORCID
Help
History (66)
Risuteganib-a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema.
The TaxUMAP atlas: Efficient display of large clinical microbiome data reveals ecological competition in protection against bacteremia.
An Indian lineage of Histoplasma with strong signatures of differentiation and selection.
Characterization of Pediatric In-Hospital Cardiopulmonary Resuscitation Quality Metrics Across an International Resuscitation Collaborative.
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
See All 66 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature. 2010 Dec 16; 468(7326):973-7.
View in:
PubMed
subject areas
Base Sequence
Cell Line, Tumor
Drug Resistance, Neoplasm
Enzyme Activation
Gene Expression Regulation, Neoplastic
Genes, ras
Humans
Indoles
MAP Kinase Signaling System
Melanoma
Mitogen-Activated Protein Kinase Kinases
Mutation
Oligonucleotide Array Sequence Analysis
Protein Kinase Inhibitors
Proto-Oncogene Proteins B-raf
Receptor Protein-Tyrosine Kinases
Receptor, Platelet-Derived Growth Factor beta
Sulfonamides
Up-Regulation
authors with profiles
Thinle Chodon
Richard Koya